Why COVID-19 patients who could most benefit from Paxlovid still aren’t getting it
American Nurse
MARCH 13, 2024
Shrunken confidence in government health programs is one reason the drug isn’t reaching those who need it. 4 issued detailed instructions to health insurers urging swift approval of Paxlovid prescriptions, given the five-day window for the drug’s efficacy. Nursing home patients, who account for around 1 in 6 U.S.
111 
Let's personalize your content